Sol-Gel Technologies
Develops topical dermatology treatments through licensees and a clinical pipeline.
$68.81
After-hours close+0.21 (+0.31%)
At close$68.60(−5.47%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$2.58 | — | — |
| Aug 2026 | −$2.36 | — | — |
| Aug 2026 | −$2.36 | −$1.13 | +52.1% |
| May 2026 | −$2.86 | −$1.31 | +54.2% |
| Mar 2026 | $0.39 | −$1.07 | −374.4% |
| Nov 2025 | −$2.09 | −$2.13 | −1.9% |
The latest year is open to everyone — the 38 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| Apr 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Feb 2018 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 19, 2026 | −$2.58 | — | — | $100.0K | — | — |
| Aug 21, 2026 | −$2.36 | — | — | $75.0K | — | — |
| Aug 20, 2026 | −$2.36 | −$1.13 | +52.1% | $75.0K | $591.0K | +688.0% |
| May 28, 2026 | −$2.86 | −$1.31 | +54.2% | $900.0K | $108.0K | −88.0% |
| Mar 19, 2026 | $0.39 | −$1.07 | −374.4% | $6.5M | $6.5M | 0.0% |
| Nov 20, 2025 | −$2.09 | −$2.13 | −1.9% | $6.5M | $400.0K | −93.8% |
The latest year is open to everyone — the 38 quarters behind it read with an account. Sign in | ||||||
| Aug 15, 2025 | ||||||
| Apr 29, 2025 | ||||||
| Mar 26, 2025 | ||||||
| Nov 15, 2024 | ||||||
| Aug 16, 2024 | ||||||
| May 20, 2024 | ||||||
| Mar 13, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 12, 2023 | ||||||
| Mar 10, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 13, 2022 | ||||||
| Mar 30, 2022 | ||||||
| Nov 11, 2021 | ||||||
| Aug 4, 2021 | ||||||
| May 13, 2021 | ||||||
| Mar 4, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 14, 2020 | ||||||
| Mar 24, 2020 | ||||||
| Nov 13, 2019 | ||||||
| Aug 13, 2019 | ||||||
| May 22, 2019 | ||||||
| Mar 21, 2019 | ||||||
| Nov 13, 2018 | ||||||
| Aug 8, 2018 | ||||||
| May 15, 2018 | ||||||
| Mar 26, 2018 | ||||||
| Feb 2, 2018 | ||||||
| Jun 30, 2017 | ||||||
| Mar 31, 2017 | ||||||
| Dec 31, 2016 | ||||||
| Sep 30, 2016 | ||||||
| Jun 30, 2016 | ||||||
| Mar 31, 2016 | ||||||